Megan Garlapow, PhD

Megan Garlapow, PhD, is the principal and owner of The Line Medical Communications, LLC, where she brings extensive experience in medical communications across diverse therapeutic areas. Dr Garlapow earned her BA in biology from the University of Chicago and her PhD in genetics from North Carolina State University. With a strong background in biomedical science and genetics, Dr Garlapow has held key roles in medical education and clinical genetics and genomics, where she honed her skills in developing strategic proposals, securing funding, delivering high-quality educational content, and composing engaging medical journalism pieces.

All articles by Megan Garlapow, PhD

  • High costs and frequent hospital visits burden patients with PBC

    Patients diagnosed with primary biliary cholangitis (PBC), particularly those who also develop cirrhosis, face frequent hospital visits and high medical costs, found a study published recently in the Journal of Comparative Effectiveness Research.  Analyzing two large healthcare databases from 2015 to 2023, researchers discovered that among patients who experienced at least one hospitalization or emergency […]